Sisram Medical Ltd.(HK:1696)
HK$1.84+0.07 (+3.95%)
HK:1696
Sisram Medical Ltd. financials statements
HK$1.84
At close:+0.07 (+3.95%)
Want to see HK:1696 full AI Analyst Report?
Sisram Medical Ltd. (1696) Ratios
3 Followers
Sisram Medical Ltd. Ratios
HK:1696's free cash flow for Q2 2026 was $-17.36M. For the 2026 fiscal year, HK:1696's free cash flow was decreased by $-328.00K and operating cash flow was $-17.03M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.60 | 2.61 | 2.92 | 3.13 | 3.56 |
| Quick Ratio | 1.72 | 1.76 | 2.00 | 2.19 | 2.79 |
| Cash Ratio | 0.67 | 0.74 | 0.80 | 1.02 | 1.83 |
| Solvency Ratio | 0.24 | 0.26 | 0.32 | 0.43 | 0.34 |
| Operating Cash Flow Ratio | 0.09 | 0.35 | 0.50 | 0.28 | 0.39 |
| Short-Term Operating Cash Flow Coverage | 0.87 | 6.90 | 9.94 | 3.84 | 4.44 |
| Net Current Asset Value | $ 122.70M | $ 106.74M | $ 113.37M | $ 127.19M | $ 171.09M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.07 | 0.07 | 0.07 | 0.08 |
| Debt-to-Equity Ratio | 0.11 | 0.09 | 0.10 | 0.10 | 0.10 |
| Debt-to-Capital Ratio | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.37 | 1.35 | 1.36 | 1.29 | 1.32 |
| Debt Service Coverage Ratio | 2.91 | 4.85 | 7.59 | 7.03 | 5.03 |
| Interest Coverage Ratio | 10.02 | 14.52 | 20.38 | 28.12 | 25.22 |
| Debt to Market Cap | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 |
| Interest Debt Per Share | 0.12 | 0.10 | 0.10 | 0.09 | 0.10 |
| Net Debt to EBITDA | -0.43 | -0.69 | -0.49 | -0.69 | -1.99 |
| Profitability Margins | |||||
| Gross Profit Margin | 58.89% | 62.07% | 61.10% | 57.05% | 56.70% |
| EBIT Margin | 7.40% | 7.93% | 10.91% | 12.97% | 14.84% |
| EBITDA Margin | 12.15% | 11.14% | 14.87% | 16.47% | 19.02% |
| Operating Profit Margin | 8.91% | 10.21% | 11.71% | 15.64% | 17.18% |
| Pretax Profit Margin | 7.81% | 9.32% | 10.33% | 12.48% | 14.16% |
| Net Profit Margin | 5.20% | 7.20% | 8.77% | 11.33% | 10.62% |
| Continuous Operations Profit Margin | 6.84% | 8.24% | 9.16% | 11.31% | 11.05% |
| Net Income Per EBT | 66.61% | 77.21% | 84.83% | 90.80% | 74.98% |
| EBT Per EBIT | 87.70% | 91.26% | 88.28% | 79.80% | 82.42% |
| Return on Assets (ROA) | 2.89% | 4.01% | 5.13% | 7.23% | 5.89% |
| Return on Equity (ROE) | 3.96% | 5.41% | 6.96% | 9.32% | 7.77% |
| Return on Capital Employed (ROCE) | 5.91% | 6.71% | 8.01% | 11.66% | 11.32% |
| Return on Invested Capital (ROIC) | 5.03% | 5.83% | 6.97% | 10.38% | 8.63% |
| Return on Tangible Assets | 4.83% | 7.02% | 8.99% | 10.06% | 8.50% |
| Earnings Yield | 7.51% | 11.02% | 10.00% | 7.55% | 5.67% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.95 | 4.21 | 4.27 | 3.92 | 3.94 |
| Payables Turnover | 6.55 | 9.91 | 17.48 | 11.42 | 9.79 |
| Inventory Turnover | 1.61 | 1.63 | 1.74 | 2.04 | 1.98 |
| Fixed Asset Turnover | 6.43 | 5.87 | 5.71 | 6.79 | 6.47 |
| Asset Turnover | 0.56 | 0.56 | 0.59 | 0.64 | 0.56 |
| Working Capital Turnover Ratio | 2.26 | 2.16 | 2.12 | 1.84 | 1.62 |
| Cash Conversion Cycle | 263.45 | 273.19 | 274.96 | 240.16 | 239.44 |
| Days of Sales Outstanding | 92.49 | 86.71 | 85.49 | 93.00 | 92.74 |
| Days of Inventory Outstanding | 226.67 | 223.31 | 210.36 | 179.13 | 183.99 |
| Days of Payables Outstanding | 55.71 | 36.83 | 20.89 | 31.97 | 37.29 |
| Operating Cycle | 319.15 | 310.02 | 295.85 | 272.13 | 276.73 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 0.07 | 0.09 | 0.05 | 0.07 |
| Free Cash Flow Per Share | 0.01 | 0.06 | 0.08 | -0.09 | 0.06 |
| Dividend Paid and CapEx Coverage Ratio | 0.93 | 2.71 | 2.30 | 0.30 | 4.52 |
| Capital Expenditure Coverage Ratio | 3.64 | 12.25 | 5.13 | 0.34 | 10.92 |
| Operating Cash Flow Coverage Ratio | 0.18 | 0.77 | 0.98 | 0.53 | 0.78 |
| Operating Cash Flow to Sales Ratio | 0.03 | 0.09 | 0.12 | 0.06 | 0.11 |
| Free Cash Flow Yield | 2.69% | 13.33% | 11.22% | -7.94% | 5.34% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 13.32 | 9.07 | 10.00 | 13.25 | 17.63 |
| Price-to-Sales (P/S) Ratio | 0.69 | 0.65 | 0.88 | 1.50 | 1.87 |
| Price-to-Book (P/B) Ratio | 0.53 | 0.49 | 0.70 | 1.24 | 1.37 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 37.16 | 7.50 | 8.91 | -12.59 | 18.72 |
| Price-to-Operating Cash Flow Ratio | 26.95 | 6.89 | 7.17 | 24.16 | 17.01 |
| Price-to-Earnings Growth (PEG) Ratio | -0.55 | -0.45 | -0.46 | 0.53 | 0.14 |
| Enterprise Value Multiple | 5.27 | 5.17 | 5.41 | 8.43 | 7.85 |
| Enterprise Value | 234.07M | 200.98M | 289.21M | 492.31M | 439.40M |
| EV to EBITDA | 5.27 | 5.17 | 5.41 | 8.43 | 7.85 |
| EV to Sales | 0.64 | 0.58 | 0.80 | 1.39 | 1.49 |
| EV to Free Cash Flow | 34.34 | 6.61 | 8.18 | -11.64 | 14.94 |
| EV to Operating Cash Flow | 24.91 | 6.08 | 6.58 | 22.34 | 13.57 |
| Tangible Book Value Per Share | 0.51 | 0.46 | 0.44 | 0.59 | 0.53 |
| Shareholders’ Equity Per Share | 1.02 | 0.99 | 0.97 | 0.92 | 0.89 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.12 | 0.12 | 0.11 | 0.09 | 0.22 |
| Revenue Per Share | 0.78 | 0.74 | 0.77 | 0.76 | 0.65 |
| Net Income Per Share | 0.04 | 0.05 | 0.07 | 0.09 | 0.07 |
| Tax Burden | 0.67 | 0.77 | 0.85 | 0.91 | 0.75 |
| Interest Burden | 1.06 | 1.18 | 0.95 | 0.96 | 0.95 |
| Research & Development to Revenue | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| SG&A to Revenue | 0.45 | 0.47 | 0.09 | 0.08 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | -0.00 | 0.00 | 0.01 | 0.00 |
| Income Quality | 0.33 | 1.02 | 1.18 | 0.50 | 0.78 |
Currency in USD
